NCT04666415

Brief Summary

Abstract: Background: Anorexia nervosa (AN) is a common pathology affecting mainly women (sex ratio 1/10), which starts most often during adolescence. The prognosis of the AN remains poor (10% of deaths and high risk of chronicity). Body dissatisfaction, disturbances in recognition and identification of body sensations are some of the key symptoms of AN. There is, however, a contrast between this consensual observation of the importance of troubles in body image in AN, and the relative deficit of specifically targeted body treatments. Our proposal for a body approach specifically dedicated to AN is based on the understanding that posture, breathing, muscle tension and body perception are closely linked to our psychological and emotional state, and are therefore disturbed in patients with AN. The purpose of this monocentric randomized controlled trial is to evaluate if a targeted osteopathic protocol treatment for AN in addition to as-usual care is significantly more effective compared to as-usual care. Methods: Seventy-two female patients meeting the inclusion criteria will be randomly assigned to one of the two treatment groups : one receiving the specific osteopathic treatment targeted for AN in addition to the as-usual care (group A) and the other one, the as-usual care (group B). The patients of group A will receive 5 sessions of osteopathic treatment for 25 minutes. Soft specific palpatory techniques on the diaphragm, digestive system and cervical region will be realized. The as-usual care is defined by the multidisciplinary approach recommended by the high authority of health. The primary outcome is the evaluation of interoceptive sensibility and secondary outcomes include clinical and psychopathology-related symptoms and assessment of somatic dysfonctions' evolution. A qualitative study will also be carried out, applying the Interpretative Phenomenological Analysis method. Patients will be included for a maximum of 14 weeks between the inclusion time and the last evaluation. Discussion: If the results of the study are positive (statistically significant effectiveness of this body approach in addition to as-usual care compared to as-usual treatment), patients with anorexia will be benefit from the possibility of additional treatment that is effective, relatively inexpensive, non-invasive and non-pharmacological.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 6, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 28, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 14, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

December 14, 2020

Status Verified

December 1, 2020

Enrollment Period

2.2 years

First QC Date

August 28, 2020

Last Update Submit

December 11, 2020

Conditions

Keywords

InteroceptionRandomized controlled trialBody approach

Outcome Measures

Primary Outcomes (3)

  • To evaluate the evolution of interoceptive sensitivity

    fMAIA scale : Multidimensional Assessment of Interoceptive Awareness, French version

    Arm 1: 3 weeks after inclusion ie 1 week before the first session, Arm 2: 3 weeks after inclusion

  • To evaluate the evolution of interoceptive sensitivity

    fMAIA scale : Multidimensional Assessment of Interoceptive Awareness, French version

    Arm 1: Before the 3rd session of osteopathic treatment, Arm 2: 3 weeks after the first questionnaires

  • To evaluate the evolution of interoceptive sensitivity

    fMAIA scale : Multidimensional Assessment of Interoceptive Awareness, French version

    Arm 1: 1 week after the 5th session of osteopathic treatment, Arm 2: 6 weeks after the first questionnaires

Secondary Outcomes (36)

  • To evaluate the evolution of weight

    Arm 1: 3 weeks after inclusion ie 1 week before the first session, Arm 2: 3 weeks after inclusion

  • To evaluate the evolution of weight

    Arm 1: Before the 3rd session of osteopathic treatment, Arm 2: 3 weeks after the first questionnaires

  • To evaluate the evolution of weight

    Arm 1: 1 week after the 5th session of osteopathic treatment, Arm 2: 6 weeks after the first questionnaires

  • To evaluate the presence of any physical pain

    Arm 1: 3 weeks after inclusion ie 1 week before the first session, Arm 2: 3 weeks after inclusion

  • To evaluate the presence of any physical pain

    Arm 1: Before the 3rd session of osteopathic treatment, Arm 2: 3 weeks after the first questionnaires

  • +31 more secondary outcomes

Study Arms (2)

Osteopathic treatment + as-usual treatment

EXPERIMENTAL

Osteopathic treatment: a protocol of 5 sessions of osteopathic treatment that have a 25 minutes duration and are spaced of around one week between two sessions. As-usual treatment: The outpatient and inpatient treatment of the patients will be done in compliance with the Health Authorities' recommendations (HAS 2010). Multi-disciplinary care is proposed, possibly involving nurses, psychologists, psychiatrists, general practitioners, gynecologists, rheumatologists, dieticians, occupational therapists, body approach specialists and social workers.

Other: Osteopathic treatment

As-usual treatment

NO INTERVENTION

As-usual treatment: The outpatient and inpatient treatment of the patients will be done in compliance with the Health Authorities' recommendations (HAS 2010). Multi-disciplinary care is proposed, possibly involving nurses, psychologists, psychiatrists, general practitioners, gynecologists, rheumatologists, dieticians, occupational therapists, body approach specialists and social workers.

Interventions

Targeted osteopathic protocol for AN : 5 sessions of osteopathic treatment that are spaced around one week between 2 sessions. Soft specific palpatory techniques on the diaphragm, digestive system and cervical region will be realized during the session of 25 minutes.

Osteopathic treatment + as-usual treatment

Eligibility Criteria

Age13 Years - 20 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • female
  • patient aged between 13 to 20 years included
  • patient has a Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-5) diagnosis of Nnorexia nervosa (restricting or binge-eating/purging types)
  • Body Mass Index (BMI) ≥ 14 kg.m-²
  • Followed up in consultation for at least 2 months or hospitalized in the psychiatry unit of Institut Mutualiste Montsouris
  • has a clinical/somatic state compatible with the conduct of osteopathic treatment sessions (prior medical advice)
  • is not in "separation period" (In the adolescent and young adult psychiatry department of Institut Mutualiste Montsouris, during a full-time hospitalization for AN, the "separation period" is linked to the establishment of a hospitalization contract between the medical team, the family and the patient. This contract will define a time of separation between the family and the patient. It is built around two axes: the final discharge weight allowing the patient to leave the service and the intermediate weight called "separation lifting weight". This lifting weight of separation is thus named because it puts an end to the first part of hospitalization that takes place in separation from the living environment of the patient (parents, friends, schooling...)
  • signed the Informed Consent Form and both parents for minor patient,
  • is not included in another research protocol.
  • male
  • patient under 13 years old or over 20 years old
  • has contraindication to osteopathic body approach sessions (fracture, recent surgery, etc.)
  • with a Body Mass Index (BMI) \< 14 kg.m-²
  • patient needs a naso-gastric tube
  • is in "separation period"
  • +3 more criteria

You may not qualify if:

  • patient has contraindication to osteopathic body approach sessions (fracture, recent surgery, somatic state not compatible with the osteopathic treatment)
  • is not covered by health insurance
  • is included in another research protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Mutualiste Montsouris

Paris, 75014, France

RECRUITING

Related Publications (1)

  • Letranchant A, Montebello YK, Bigre CD, Wagner A, Curt F, Silva J, Nicolas I, Votadoro P, Kalindjian N, Korchonnoff A, Gutierre A, Novelli AB, Pham-Scottez A, Corcos M. The ACAMTO study-impact of add-on osteopathic treatment on adolescent patients with anorexia nervosa: study protocol for a randomized controlled trial. Trials. 2021 Nov 24;22(1):839. doi: 10.1186/s13063-021-05810-8.

MeSH Terms

Conditions

Anorexia Nervosa

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Aurélie LETRANCHANT, M.D.

    Institut Mutualiste Montsouris

    PRINCIPAL INVESTIGATOR
  • Maurice CORCOS, M.D., Ph.D.

    Institut Mutualiste Montsouris

    STUDY DIRECTOR

Central Study Contacts

Aurélie LETRANCHANT, M.D.

CONTACT

Isabelle SAURET

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessor of the clinical and psychological outcomes (research psychologist) will be blinded to the treatment group and will use standardized research questionnaires. Assessors of the osteopathic outcomes will not perform the osteopathic sessions, to guarantee an independent evaluation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 28, 2020

First Posted

December 14, 2020

Study Start

February 6, 2020

Primary Completion

April 1, 2022

Study Completion

April 1, 2022

Last Updated

December 14, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations